The role of macrophage plasticity in neurodegenerative diseases

• Published in: Biomarker research Vol. 12; no. 1; pp. 1 - 29
• Main Authors: Ma, Hongyue, Zhu, Mingxia, Chen, Mengjie, Li, Xiuli, Feng, Xinhong
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 13.08.2024; BioMed Central; BMC
• Subjects: Alzheimer's disease; Amyotrophic lateral sclerosis; Antigens; B cells; Bone marrow; Development and progression; Gene expression; Genetic aspects; Genome-wide association studies; Genomes; Genomics; Growth factors; Health aspects; Homeostasis; Imaging methodologies; Immune cells; Immune clearance; Infections; Inflammation; Innate immunity; Liver; Macrophages; Medical research; Medicine, Experimental; Nervous system diseases; Neural plasticity; Neurodegenerative disease; Neurodegenerative diseases; Neuroimaging; Physiological aspects; Physiology; Proteins; Review; Risk factors; Therapeutic applications; Transcription factors; β-Amyloid
• ISSN: 2050-7771; 2050-7771
• DOI: 10.1186/s40364-024-00624-7

Tissue-resident macrophages and recruited macrophages play pivotal roles in innate immunity and the maintenance of brain homeostasis. Investigating the involvement of these macrophage populations in eliciting pathological changes associated with neurodegenerative diseases has been a focal point of research. Dysregulated states of macrophages can compromise clearance mechanisms for pathological proteins such as amyloid-[beta] (A[beta]) in Alzheimer's disease (AD) and TDP-43 in Amyotrophic lateral sclerosis (ALS). Additionally, recent evidence suggests that abnormalities in the peripheral clearance of pathological proteins are implicated in the pathogenesis and progression of neurodegenerative diseases. Furthermore, numerous genome-wide association studies have linked genetic risk factors, which alter the functionality of various immune cells, to the accumulation of pathological proteins. This review aims to unravel the intricacies of macrophage biology in both homeostatic conditions and neurodegenerative disorders. To this end, we initially provide an overview of the modifications in receptor and gene expression observed in diverse macrophage subsets throughout development. Subsequently, we outlined the roles of resident macrophages and recruited macrophages in neurodegenerative diseases and the progress of targeted therapy. Finally, we describe the latest advances in macrophage imaging methods and measurement of inflammation, which may provide information and related treatment strategies that hold promise for informing the design of future investigations and therapeutic interventions.